Current pharmacological treatment landscape Current management of CKD in type 1 diabetes centres on glycaemic control, RAS inhibition and optimisation of risk factors including blood pressure, lipids and body weight [1, 16]
Wagner, Jiahui (Rose) Wang, David Schwartz and John Vielandi of Labaton Keller Sucharow LLP, Peter B
Maintenance vs
Several commonly prescribed drugs are associated with weight gain, including: Certain antidepressants (e.g., mirtazapine, amitriptyline) Antipsychotics (e.g., olanzapine, quetiapine) Corticosteroids Some antiepileptics (e.g., valproate, gabapentin, pregabalin) and antidiabetic agents (e.g., insulin, sulphonylureas) Other agents such as beta-blockers and pizotifen If you are concerned that a medicine may be contributing to weight gain, speak to your prescriber before making any changes do not stop prescribed medication without medical advice